7-90385035-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033107.4(GTPBP10):āc.1045C>Gā(p.Gln349Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,461,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_033107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GTPBP10 | NM_033107.4 | c.1045C>G | p.Gln349Glu | missense_variant | 10/10 | ENST00000222511.11 | NP_149098.2 | |
GTPBP10 | NM_001042717.3 | c.808C>G | p.Gln270Glu | missense_variant | 8/8 | NP_001036182.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GTPBP10 | ENST00000222511.11 | c.1045C>G | p.Gln349Glu | missense_variant | 10/10 | 1 | NM_033107.4 | ENSP00000222511 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251276Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135808
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461658Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727132
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.1045C>G (p.Q349E) alteration is located in exon 10 (coding exon 10) of the GTPBP10 gene. This alteration results from a C to G substitution at nucleotide position 1045, causing the glutamine (Q) at amino acid position 349 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at